Opportunity Radar

← Back to search

Grant

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

View on Grants.gov ↗ Sign in to save

Type
Grant
Notice type
G
Agency
National Institutes of Health
Sub-agency
HHS-NIH11
Solicitation #
PAR-25-321
Posted
Dec 10, 2024
Response due
Jan 7, 2028
Archive date
Feb 12, 2028
CFDA / Assistance listing
93.393,93.394,93.395,93.396,93.399
Contact
grantsinfo@nih.gov
Source
Grants.gov

Description

Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility.

Similar open opportunities